S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
OTCMKTS:ARESF

Artis Real Estate Investment Trust (ARESF) Stock Price, News & Analysis

$4.69
+0.10 (+2.18%)
(As of 04:27 PM ET)
Today's Range
$4.69
$4.71
50-Day Range
$4.15
$4.88
52-Week Range
$4.07
$5.53
Volume
10,401 shs
Average Volume
14,696 shs
Market Capitalization
N/A
P/E Ratio
4.91
Dividend Yield
17.27%
Price Target
$12.38

Artis Real Estate Investment Trust MarketRank™ Stock Analysis

Analyst Rating
0.00 Rating Score
Upside/​Downside
169.6% Upside
$12.38 Price Target
Short Interest
Bearish
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
1.71mentions of Artis Real Estate Investment Trust in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.68 out of 5 stars

ARESF stock logo

About Artis Real Estate Investment Trust Stock (OTCMKTS:ARESF)

Artis is a diversified Canadian real estate investment trust with a portfolio of industrial, office and retail properties in Canada and the United States. Artis's vision is to build a best-in-class asset management and investment platform focused on growing net asset value per unit and distributions for investors through value investing in real estate.

ARESF Stock Price History

ARESF Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Artis Real Estate Investment Trust
Stocks in play: Artis Real Estate Investment Trust.
Artis Real Estate Investment Trust AX.UN
See More Headlines
Receive ARESF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Artis Real Estate Investment Trust and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 3/15 Dividend
2/28/2024
Dividend Payable
3/15/2024
Ex-Dividend for 4/15 Dividend
3/27/2024
Dividend Payable
4/15/2024
Today
4/19/2024
Next Earnings (Estimated)
5/09/2024

Industry, Sector and Symbol

Industry
REIT - Diversified
Sub-Industry
N/A
Current Symbol
OTCMKTS:ARESF
CIK
N/A
Fax
N/A
Employees
169
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$12.38
High Stock Price Target
$13.00
Low Stock Price Target
$11.75
Potential Upside/Downside
+169.6%
Consensus Rating
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Ms. Kim Riley (Age 40)
    Chief Operating Officer
    Comp: $360.83k
  • Mr. Philip Martens
    Executive Vice President of U.S. Region
  • Mr. Leon R. Wilkosz
    Senior Vice President of Asset Management - Wisconsin
  • Ms. Danielle Robert
    Vice President of Accounting
  • Ms. Heather Nikkel
    Senior Vice President of Investor Relations & Sustainability
  • Ms. Kara Watson
    Vice President of Legal
  • Ms. Jayelle Morris
    Vice President of Human Resources
  • Mr. Brad Goerzen
    Senior Vice President of Leasing - Central Region
  • Ms. Marie Dunn
    Senior Vice President of Asset Management - U.S. Region
  • Mr. Ron Wieler
    Senior Vice President of Construction & Development - U.S. Region

ARESF Stock Analysis - Frequently Asked Questions

What is Artis Real Estate Investment Trust's stock price target for 2024?

0 brokerages have issued 12 month target prices for Artis Real Estate Investment Trust's stock. Their ARESF share price targets range from $11.75 to $13.00. On average, they expect the company's share price to reach $12.38 in the next year. This suggests a possible upside of 169.6% from the stock's current price.
View analysts price targets for ARESF
or view top-rated stocks among Wall Street analysts.

How have ARESF shares performed in 2024?

Artis Real Estate Investment Trust's stock was trading at $5.0060 at the start of the year. Since then, ARESF stock has decreased by 8.3% and is now trading at $4.59.
View the best growth stocks for 2024 here
.

Are investors shorting Artis Real Estate Investment Trust?

Artis Real Estate Investment Trust saw a increase in short interest in March. As of March 31st, there was short interest totaling 1,889,500 shares, an increase of 8.1% from the March 15th total of 1,748,000 shares. Based on an average daily volume of 14,700 shares, the short-interest ratio is currently 128.5 days.
View Artis Real Estate Investment Trust's Short Interest
.

When is Artis Real Estate Investment Trust's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our ARESF earnings forecast
.

How often does Artis Real Estate Investment Trust pay dividends? What is the dividend yield for Artis Real Estate Investment Trust?

Artis Real Estate Investment Trust declared a dividend on Thursday, March 21st. Shareholders of record on Thursday, March 28th will be paid a dividend of $0.037 per share on Monday, April 15th. This represents a yield of 9.89%. The ex-dividend date is Wednesday, March 27th.
Read our dividend analysis for ARESF
.

Is Artis Real Estate Investment Trust a good dividend stock?

Artis Real Estate Investment Trust (OTCMKTS:ARESF) pays an annual dividend of $0.81 per share and currently has a dividend yield of 7.85%. ARESF has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 84.74%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for ARESF.

How do I buy shares of Artis Real Estate Investment Trust?

Shares of ARESF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:ARESF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners